Abrdn Life Sciences Investors (HQL) Short Interest Ratio & Short Volume → This Wall Street stock prediction just went viral (From Chaikin Analytics) (Ad) Free HQL Stock Alerts $14.27 +0.22 (+1.57%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Abrdn Life Sciences Investors Short Interest DataCurrent Short Volume58,400 sharesPrevious Short Volume19,100 sharesChange Vs. Previous Month+205.76%Dollar Volume Sold Short$765,624.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares27,350,000 sharesPercentage of Shares Shorted0.21%Today's Trading Volume109,070 sharesAverage Trading Volume107,462 sharesToday's Volume Vs. Average101% Short Selling Abrdn Life Sciences Investors ? Sign up to receive the latest short interest report for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHQL Short Interest Over TimeHQL Days to Cover Over TimeHQL Percentage of Float Shorted Over Time Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth Abrdn Life Sciences Investors Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202458,400 shares $765,624.00 +205.8%N/A0.6 $13.11 4/15/202419,100 shares $247,918.00 -10.3%N/A0.2 $12.98 3/31/202421,300 shares $290,319.00 -27.6%N/A0.2 $13.63 3/15/202429,400 shares $396,900.00 -47.5%N/A0.2 $13.50 2/29/202456,000 shares $767,200.00 -58.0%N/A0.4 $13.70 2/15/2024133,400 shares $1.87 million +895.5%N/A1 $14.05 Get the Latest News and Ratings for HQL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. 1/31/202413,400 shares $183,848.00 -86.2%N/A0.1 $13.72 1/15/202496,900 shares $1.37 million +37.1%N/A0.8 $14.16 12/31/202370,700 shares $951,622.00 +30.2%N/A0.5 $13.46 12/15/202354,300 shares $714,045.00 +18.0%N/A0.4 $13.15 11/30/202346,000 shares $549,240.00 -51.0%N/A0.4 $11.94 11/15/202393,800 shares $1.13 million +186.0%N/A0.8 $12.04 10/31/202332,800 shares $380,152.00 -42.9%N/A0.3 $11.59 10/15/202357,400 shares $704,872.00 +71.9%N/A0.5 $12.28 9/30/202333,400 shares $416,498.00 -7.2%N/A0.3 $12.47 9/15/202336,000 shares $461,880.00 +40.1%N/A0.4 $12.83 8/31/202325,700 shares $334,357.00 +71.3%N/A0.3 $13.01 8/15/202315,000 shares $201,300.00 -63.0%N/A0.2 $13.42 7/31/202340,500 shares $544,725.00 +282.1%N/A0.4 $13.45 7/15/202310,600 shares $142,146.00 -85.7%N/A0.1 $13.41 6/30/202374,000 shares $1.00 million +695.7%N/A1 $13.55 6/15/20239,300 shares $128,712.00 No ChangeN/A0.1 $13.84 5/31/20239,300 shares $123,597.00 -76.6%N/A0.1 $13.29 5/15/202339,800 shares $559,588.00 -27.2%N/A0.5 $14.06 4/30/202354,700 shares $761,971.00 -2.0%N/A0.7 $13.93 4/15/202355,800 shares $782,874.00 -1.8%N/A0.7 $14.03 3/31/202356,800 shares $791,224.00 -45.8%N/A0.7 $13.93 3/15/2023104,700 shares $1.44 million +408.3%N/A1 $13.72 2/28/202320,600 shares $287,576.00 +186.1%N/A0.2 $13.96 2/15/20237,200 shares $105,336.00 -22.6%N/A0.1 $14.63 1/31/20239,300 shares $138,942.00 -17.7%N/A0.1 $14.94 1/15/202311,300 shares $166,788.00 -50.9%N/A0.1 $14.76 12/30/202223,000 shares $326,830.00 +62.0%N/A0.2 $14.21 12/15/202214,200 shares $209,024.00 -10.7%N/A0.1 $14.72 11/30/202215,900 shares $239,772.00 +28.2%N/A0.2 $15.08 11/15/202212,400 shares $186,620.00 +7.8%N/A0.1 $15.05 10/31/202211,500 shares $168,475.00 -62.9%N/A0.1 $14.65 10/15/202231,000 shares $427,490.00 No ChangeN/A0.4 $13.79 9/30/202224,000 shares $327,840.00 -33.9%N/A0.3 $13.66 9/15/202236,300 shares $537,240.00 +80.6%N/A0.5 $14.80He cracked the code to crypto… (Ad)Juan Villaverde has cracked the code to crypto.Click now for the best way into the newest AI projects HQL Short Interest - Frequently Asked Questions What is Abrdn Life Sciences Investors' current short interest? Short interest is the volume of Abrdn Life Sciences Investors shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 58,400 shares of HQL short. Learn More on Abrdn Life Sciences Investors' current short interest. What is a good short interest ratio for Abrdn Life Sciences Investors? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HQL shares currently have a short interest ratio of 1.0. Learn More on Abrdn Life Sciences Investors's short interest ratio. Is Abrdn Life Sciences Investors' short interest increasing or decreasing? Abrdn Life Sciences Investors saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 58,400 shares, an increase of 205.8% from the previous total of 19,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Abrdn Life Sciences Investors' short interest compare to its competitors? Here is how the short interest of companies in the industry of "investment offices, not elsewhere classified" compare to Abrdn Life Sciences Investors: Barings Corporate Investors (0.06%), DWS Municipal Income Trust (0.11%), Tortoise Energy Infrastructure Co. (0.14%), BlackRock MuniYield New York Quality Fund, Inc. (0.26%), Source Capital, Inc. (0.04%), Putnam Premier Income Trust (0.13%), Horizon Technology Finance Co. (1.71%), BlackRock MuniYield Michigan Quality Fund, Inc. (0.04%), BlackRock MuniAssets Fund, Inc. (0.30%), BlackRock MuniHoldings New York Quality Fund, Inc. (0.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Abrdn Life Sciences Investors stock? Short selling HQL is an investing strategy that aims to generate trading profit from Abrdn Life Sciences Investors as its price is falling. HQL shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abrdn Life Sciences Investors? A short squeeze for Abrdn Life Sciences Investors occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HQL, which in turn drives the price of the stock up even further. How often is Abrdn Life Sciences Investors' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HQL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Barings Corporate Investors Short Interest Data DWS Municipal Income Trust Short Interest Data Tortoise Energy Infrastructure Short Interest Data BlackRock MuniYield New York Quality Fund Short Interest Data Source Capital Short Interest Data Putnam Premier Income Trust Short Interest Data Horizon Technology Finance Short Interest Data BlackRock MuniYield Michigan Quality Fund Short Interest Data BlackRock MuniAssets Fund Short Interest Data BlackRock MuniHoldings New York Quality Fund Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:HQL) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders